|
GB0003782D0
|
|
Process
|
|
AU6919598A
|
|
A novel bioadhesive drug delivery system based on liquid crystals
|
|
AU5310898A
|
|
Release-controlled coated tablets
|
|
AU4941297A
|
|
A method for promoting tissue repair
|
|
US5958458A
|
|
Pharmaceutical multiple unit particulate formulation in the form of coated cores
|
|
EP0764169A2
|
|
Drug salts
|
|
WO9526715A2
|
|
Use of fatty acid esters as bioadhesive substances
|
|
GB9505021D0
|
|
Drag salts
|
|
US6077822A
|
|
Drug salts
|
|
US5538954A
|
|
Salts of tetracyclines
|
|
GB9409778D0
|
|
Compositions
|
|
DK103493D0
|
|
New salts of aminoglycosides
|
|
DK145792D0
|
|
fluid dispensing apparatus
|
|
IL95924A
|
|
Composition for controlled delivery of biologically active agents
|
|
US5143934A
|
|
Method and composition for controlled delivery of biologically active agents
|
|
DK254289D0
|
|
MEASURES FOR TREATING Fungal INFECTIONS
|
|
DK580488D0
|
|
Procedure for preparing a tabletable pharmaceutical mixture
|
|
DK580588D0
|
|
Triazolobenzodiazepiner
|
|
DK181988D0
|
|
Thiocarbamic acid residues for use as a therapeutic and preparation for the treatment of alcohol abuse
|
|
DK76988D0
|
|
Container with screw cover including a security
|
